Form 8-K - Current report:
SEC Accession No. 0000950170-25-042331
Filing Date
2025-03-20
Accepted
2025-03-20 08:05:58
Documents
13
Period of Report
2025-03-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ivvd-20250320.htm   iXBRL 8-K 57580
2 EX-99.1 ivvd-ex99_1.htm EX-99.1 223233
3 GRAPHIC img59752938_0.jpg GRAPHIC 85687
  Complete submission text file 0000950170-25-042331.txt   541350

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20250320.xsd EX-101.SCH 31867
15 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20250320_htm.xml XML 4874
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 25754555
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)